Bringing the Oncology Community Together

Login | Register
Home CME OncLive TV Peer Exchange Urology Research iPubs Meetings Blogs Practice Management Partners Publications


Dr. Morris Discusses PET Imaging in Prostate Cancer
Latest Bone Mets Articles
  • Radium-223 Approved For Advanced Prostate Cancer
  • Bone-Targeted Therapies Evolve in Prostate Cancer
  • Trials in Progress: Bone Metastases
  • Microwave Ablation Is Potentially Effective in Treating Bone and Soft-Tissue Tumor Pain

    • My OncLive >>


    Chip Petricoin on the Discovery of New Biomarkers
    Latest Breast Cancer Articles
  • Resistance Poses Challenges in Chemotherapy Options
  • LUX Program Examines Pan-HER Inhibitor Afatinib in Multiple Tumor Types
  • A National Dialogue on Genetic Testing for Breast Cancer
  • Sledge Expects “Big Data” to Generate Big Changes

    • My OncLive >>


    Determining Optimal Treatments in mCRC
    Latest Gastrointestinal Cancer Articles
  • What Is the Role of Maintenance Therapy in Cancer Care?
  • Advances in the Management of Hepatic and Pancreatic Malignancies
  • (Molecular) Pathways, Pathways, and More Pathways
  • Imatinib Therapy Matures: GIST Research Sheds Light on Mutations, Drug Levels

    • My OncLive >>


    Dr. Morris on rPFS as an Endpoint in Clinical Trials
    Latest Genitourinary Cancer Articles
  • Ablative Therapies for Small Renal Masses
  • Beyond Provenge: The Next Steps With Immunotherapy in Prostate Cancer
  • Radium-223 Approved For Advanced Prostate Cancer
  • Bone-Targeted Therapies Evolve in Prostate Cancer

    • My OncLive >>


    Dr. Sherman Discusses the Development of Selumetinib
    Latest Head & Neck Cancers and Brain Cancers Articles
  • Four Head and Neck Cancer Highlights From ASCO 2013
  • New Method of Predicting Head and Neck Cancer Survival Explored
  • LUX Program Examines Pan-HER Inhibitor Afatinib in Multiple Tumor Types
  • New Drug Potentially Blocks HPV from Causing Head and Neck Cancer

    • My OncLive >>


    Primary Management of Advanced Hodgkin Lymphoma
    Latest Hematologic Malignancies Articles
  • Pfizer Discontinues Late-Stage Trial of Inotuzumab Ozogamicin
  • What Really Matters?
  • JAK2 Inhibitor Shows Promise in Myelofibrosis
  • Breakthrough Designation Granted to Daratumumab for Double Refractory Multiple Myeloma

    • My OncLive >>


    Dr. Camidge on Targeted Therapies in Adjuvant NSCLC
    Latest Lung Cancer Articles
  • LUX Program Examines Pan-HER Inhibitor Afatinib in Multiple Tumor Types
  • FDA Approves Frontline Erlotinib With Novel Companion Diagnostic for Advanced NSCLC
  • Serendipity in Science: NSCLC Specialist Matches Therapies With Targets
  • What Is the Role of Maintenance Therapy in Cancer Care?

    • My OncLive >>


    Dr. Sekulic on Vismodegib for Basal-Cell Nevus Syndrome
    Latest Melanoma and Skin Cancer Articles
  • ODAC Turns Down Chemosaturation System
  • PD-1 Targeted Antibody Lambrolizumab Receives FDA Breakthrough Designation
  • The Effect of Ipilimumab on Health-Related Quality of Life in Patients With Unresectable Advanced Melanoma
  • The Economic Value of Ipilimumab as a Second-Line Treatment in Patients With Advanced Melanoma

    • My OncLive >>


    Dr. Morris on rPFS as an Endpoint in Clinical Trials
    Latest Prostate Cancer Articles
  • Beyond Provenge: The Next Steps With Immunotherapy in Prostate Cancer
  • Radium-223 Approved For Advanced Prostate Cancer
  • Bone-Targeted Therapies Evolve in Prostate Cancer
  • Integrating New Therapies Into the Prostate Cancer Continuum

    • My OncLive >>


    Marianne Davies on Evidence- Based Practice at YNHH
    Latest Nurses Articles
  • Counseling BRCA, Lynch Carriers on Prophylactic Oophorectomy
  • Journal Club Bridges Research and Practice, Improving Patient Care
  • Nurses Leading the Way: Promoting Adherence to Oral Cancer Medications
  • Dermatology Expert Discusses Challenges Facing Cancer Patients

    • My OncLive >>


    Management of Hodgkin Lymphoma in Elderly Patients
    Latest Supportive Care Articles
  • Anticipatory and Delayed Nausea Remain Concerns for Patients on Chemotherapy
  • Dermatology Expert Discusses Challenges Facing Cancer Patients
  • Managing Menopausal Symptoms in Breast Cancer Patients
  • Nurse-Guided Symptom Management Improves Fatigue in Advanced Cancers

    • My OncLive >>


    Dr. Tanyi Describes a Novel Two-Step Immunotherapy
    Latest Ovarian Cancer Articles
  • Counseling BRCA, Lynch Carriers on Prophylactic Oophorectomy
  • Worldwide Effort Yields Major Advances in Identifying Genetic Risks for Breast, Prostate, and Ovarian Cancer
  • Intraperitoneal Chemotherapy Improves Survival in Ovarian Cancer Patients With Low BRCA1 Levels
  • US Supreme Court Hears Arguments in BRCA1/2 Patenting Case

    • My OncLive >>

    Urology

    - A Network of Your Peers More Urology Videos >>
    Dr. Morris on rPFS as an Endpoint in Clinical Trials
    Dr. Sandler on Radiation Therapy for Prostate Cancer
    Dr. Crawford on Sequences and Combinations in CRPC
    Dr. Karsh Discusses Treatment Sequencing in mCRPC
    Latest Urology Articles View more >>
    Ablative Therapies for Small Renal Masses
    Ablative Therapies for Small Renal Masses
    A peer-reviewed summary of the ablative techniques currently available for the treatment of small renal masses.
    Contemporary Oncology   >   Articles
    Beyond Provenge: The Next Steps With Immunotherapy in Prostate Cancer
    Beyond Provenge: The Next Steps With Immunotherapy in Prostate Cancer
    Susan F. Slovin, MD, PhD, from Memorial Sloan-Kettering Cancer Center, provides an overview of the most promising immunotherapeutic follow-ups to sipuleucel-T in prostate cancer.
    Oncology & Biotech News   >   Conference Highlights
    Radium-223 Approved For Advanced Prostate Cancer
    Radium-223 Approved For Advanced Prostate Cancer
    The FDA approved radium RA 223 dichloride for the treatment of symptomatic metastatic castration-resistant prostate cancer that has spread to the bones but not to any other organs.
      >   Web Exclusives
    Bone-Targeted Therapies Evolve in Prostate Cancer
    Bone-Targeted Therapies Evolve in Prostate Cancer
    The treatment of bone metastases in prostate cancer has changed over the years, and several options are now either available or under development.
      >   Web Exclusives
    Integrating New Therapies Into the Prostate Cancer Continuum
    Integrating New Therapies Into the Prostate Cancer Continuum
    Several case studies highlighting the latest strategies and therapeutic agents available for patients with prostate cancer.
    Urologists in Cancer Care   >   Case-Based Discussion
    Publication Spotlight
    Urologists in Cancer Care

    Urologists in
    Cancer Care

    Clinical Trials
    IS There a Correlation Between Sypmtoms of Gastroparesis and the Duration of Video Caspule Retention in the Stomach
    12 May 2013
    Pharmacokinetics and Safety of Regorafenib (BAY73-4506) in Cancer Subjects With Severe Renal Impairment
    10 May 2013
    Periodontal Disease as a Risk Indicator for Erectile Dysfunction - A Cross-sectional Study on 100 Patients
    6 May 2013
    Upcoming Meetings
    Expanding Targets in Lung Cancer (2013)
    June 2, 2013
    Chicago, IL
    12th International Congress on the Future of Breast Cancer® (2013)
    July 18 - 20, 2013
    Huntington Beach, CA
    14th International Lung Cancer Congress® (2013)
    July 25 - 27, 2013
    Huntington Beach, CA
    11th International Congress on Targeted Therapies in Cancer® (2013)
    Aug 16 & 17, 2013
    Washington, DC
    11th Annual School of Breast Oncology® (2013)
    Nov 7-10, 2013
    Atlanta, GA
    8th Annual New York Lung Cancer Symposium® (2013)
    Nov 9, 2013
    New York, NY
    18th International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and Myeloma (2014)
    Feb 14-15, 2014
    New York, NY
    Publications
    External Resources

    American Journal of Managed Care
    HCPLive
    PainLive
    Pharmacy Times
    Physicians' Education Resource
    Physician's Money Digest
    Specialty Pharmacy Times
    TargetedHC
    OncLive Resources

    Archives
    Blogs
    OncLive TV
    Oncology Nurses
    Publications
    Specialties
    Web Exclusives


    About Us
    Advertise
    Advisory Board
    Contact Us
    Forgot Password
    Privacy Policy
    Terms & Conditions
    Intellisphere, LLC
    666 Plainsboro Road
    Building 300
    Plainsboro, NJ 08536
    P: 609-716-7777
    F: 609-716-4747

    Copyright OncLive 2006-2013
    Intellisphere, LLC. All Rights Reserved.